Normal values of B type natriuretic peptide in infants, children, and adolescents.
about
Factors associated with serum B-type natriuretic peptide in infants with single ventriclesDiagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases.B-type natriuretic peptide: prognostic marker in congenital diaphragmatic herniaThe sexual dimorphism of obesity.Factors associated with serum brain natriuretic peptide levels after the Fontan procedure.Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injuryUsefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.Acute B-type natriuretic peptide response and early postoperative right ventricular physiology following tetralogy of Fallot's repair.Early Elevated B-Type Natriuretic Peptide Levels are Associated with Cardiac Dysfunction and Poor Clinical Outcome in Pediatric Septic Patients.Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals.Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?N-terminal probrain natriuretic peptide level inversely correlates with cardiac index after arterial switch operation in neonates.N-terminal pro-brain natriuretic peptide measurements in hemodynamically significant patent ductus arteriosus in preterm infants.Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertensionThe clinical utility of brain natriuretic peptide in paediatric left ventricular failure.Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology.Preoperative B-type natriuretic peptide levels are associated with outcome after total cavopulmonary connection (Fontan).Practical application of natriuretic peptides in paediatric cardiology.Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation.Patent ductus arteriosus in preterm infants.Cardiac biomarkers in neonatal hypoxic ischaemia.The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.The untapped potential of proteomic analysis in pediatric pulmonary hypertension.BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.Cardiac biomarkers in children with congenital heart disease.Myocardial and haemodynamic responses to two fluid regimens in African children with severe malnutrition and hypovolaemic shock (AFRIM study).Cardiac biomarkers in pediatric heart disease: A state of art review.NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study.Non-shivering thermogenesis as a mechanism to facilitate sustainable weight loss.Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study.Intravenous rehydration of malnourished children with acute gastroenteritis and severe dehydration: A systematic reviewMid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: effect of gender and pubertal stage.NT-proBNP Levels Improve the Ability of Predicting a Hemodynamically Significant Patent Ductus Arteriosus in Very Low-Birth-Weight Infants.Saw-tooth cardiomyopathy.Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.Preoperative factors as a predictor for early postoperative outcomes after repair of congenital transposition of the great arteries.
P2860
Q33591017-17D497A1-A677-4E66-9E1A-A0BA6386909EQ33810576-A1A9CC8E-7FA2-44CD-BBB1-78F46F8FE4EBQ34516884-878EFB47-EF9F-4CE0-8AD0-888F5CE78E28Q35077539-F21FACE0-0D31-4292-BC05-355DACB76B14Q35100028-70A3682A-E1F1-4DE0-B2F3-F71F32A42A34Q35270079-333CB246-03EB-4141-A9BA-BCB28B6CCE35Q35508045-1FAA0C40-B8E1-459C-9CBB-6A818F21BB9EQ35593180-22034805-CF19-4E5A-9D13-BF5EA3138948Q35803749-DA886719-0700-4AF9-8A9B-142997360224Q35968889-970EC4F7-127F-476D-B27D-396D22C46F74Q36175452-D26F3FCF-C25C-4F8B-A198-5FD212B899C6Q36721760-3C732B20-6994-49FA-83D5-464E9C81E46FQ36797141-0D7E829C-E9A5-4B24-83D4-FFE290414227Q36856379-7B552275-25AF-4220-B323-AF4584622F17Q36862707-1BA966F9-E641-43EC-9BB7-B49D6866B4B0Q37055084-2B7BE507-190C-4BFE-ADEE-792EC85A73E9Q37274564-63C97484-3CB7-4DA3-8658-CFD11F62E813Q37369560-6EF47BA3-0A64-437B-B81E-3F468C24F4B1Q37470315-26ED2B74-C3DC-4367-8955-7AA578F9DA39Q37669708-4B501156-7C2F-4342-94BC-70C1A129E519Q37748955-741848D7-545E-46ED-BC9B-F75D7201B60CQ37801768-8B003F5D-F927-4AA8-9278-F8120D7D208CQ37870606-19E9D2F8-E223-443D-9105-11B7C3B27458Q37961207-E5AF7C65-D231-46E0-87DA-D1D963A91323Q38182858-95188957-BDED-47B6-B5F0-AB008D55B827Q38263034-1331CF29-2466-4D0F-9C9B-FD15E5F9EDCFQ38324210-BF93AB47-E5E5-48C3-A83E-DC536DF27AC1Q38571881-566E70F0-3AFB-4B3C-B4F8-00A2AADF7CD3Q38603770-8FD72991-2E30-4EFF-872B-958E0148D735Q38806580-40F5F32A-8E7B-4894-B8DF-F21F73D5DF35Q39030343-45E9E712-0881-44A1-A07C-0499EB74A211Q39165884-8A6532D8-B6CA-45A0-8BF5-EC6E8E118276Q39332205-726D8BB3-79ED-48C3-AF53-1F04948E7BA8Q40183631-9AC3C374-3CC4-43D8-9B2F-0E1F4CB72333Q41528562-1F464ED5-FCD7-459A-AB8E-1C6FBBCACEFDQ41742263-47F55CAB-96E2-45C4-89A1-9721605CEBA6Q41815458-AD9CA517-467D-4710-B66B-09B9CCC042B5Q42943565-7C9E1BB8-74DD-42E9-BA96-3E68C2FF374DQ43411818-0CF74027-307F-4BE8-B168-319772716C9DQ43522743-9C099B4A-5721-428E-9CD8-2DD6F532BF5B
P2860
Normal values of B type natriuretic peptide in infants, children, and adolescents.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@ast
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@en
type
label
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@ast
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@en
prefLabel
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@ast
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@en
P2860
P356
P1433
P1476
Normal values of B type natriuretic peptide in infants, children, and adolescents.
@en
P2860
P304
P356
10.1136/HEART.89.8.875
P407
P577
2003-08-01T00:00:00Z